These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cost-Effectiveness Analysis of Myopia Progression Interventions in Children. Agyekum S; Chan PP; Adjei PE; Zhang Y; Huo Z; Yip BHK; Ip P; Wong ICK; Zhang W; Tham CC; Chen LJ; Zhang XJ; Pang CP; Yam JC JAMA Netw Open; 2023 Nov; 6(11):e2340986. PubMed ID: 37917061 [TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Atropine Combined With Orthokeratology in Slowing Axial Elongation of Myopia Children: A Meta-Analysis. Gao C; Wan S; Zhang Y; Han J Eye Contact Lens; 2021 Feb; 47(2):98-103. PubMed ID: 33060414 [TBL] [Abstract][Full Text] [Related]
9. The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article). Yu Y; Liu J Medicine (Baltimore); 2022 May; 101(18):e29191. PubMed ID: 35550467 [TBL] [Abstract][Full Text] [Related]
10. Combined Orthokeratology with Atropine for Children with Myopia: A Meta-Analysis. Wang S; Wang J; Wang N Ophthalmic Res; 2021; 64(5):723-731. PubMed ID: 32781450 [TBL] [Abstract][Full Text] [Related]
11. Effect of Combining 0.01% Atropine with Soft Multifocal Contact Lenses on Myopia Progression in Children. Jones JH; Mutti DO; Jones-Jordan LA; Walline JJ Optom Vis Sci; 2022 May; 99(5):434-442. PubMed ID: 35511120 [TBL] [Abstract][Full Text] [Related]
12. Interventions to retard myopia progression in children: an evidence-based update. Saw SM; Shih-Yen EC; Koh A; Tan D Ophthalmology; 2002 Mar; 109(3):415-21; discussion 422-4; quiz 425-6, 443. PubMed ID: 11874738 [TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis. Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360 [TBL] [Abstract][Full Text] [Related]
14. [TREATMENTS FOR SLOWING THE PROGRESSION OF MYOPIA]. Erdinest N; Morad Y Harefuah; 2017 Nov; 156(11):720-724. PubMed ID: 29198091 [TBL] [Abstract][Full Text] [Related]
15. Comparison of 0.02% atropine eye drops, peripheral myopia defocus design spectacle lenses, and orthokeratology for myopia control. Wang M; Ji N; Yu SA; Liang LL; Ma JX; Fu AC Clin Exp Optom; 2024 Nov; 107(8):813-819. PubMed ID: 38043135 [TBL] [Abstract][Full Text] [Related]
16. The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis. Gao Y; Yu Y Medicine (Baltimore); 2022 Jun; 101(22):e29409. PubMed ID: 35665735 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the long-term effects of atropine in combination with Orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents. Tang T; Lu Y; Li X; Zhao H; Wang K; Li Y; Zhao M Eye (Lond); 2024 Jun; 38(9):1660-1667. PubMed ID: 38418604 [TBL] [Abstract][Full Text] [Related]
18. Repeated Low-Level Red Light Therapy for the Control of Myopia in Children: A Meta-Analysis of Randomized Controlled Trials. Wang F; Peng W; Jiang Z Eye Contact Lens; 2023 Oct; 49(10):438-446. PubMed ID: 37565498 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children: A Network Meta-Analysis. Ha A; Kim SJ; Shim SR; Kim YK; Jung JH Ophthalmology; 2022 Mar; 129(3):322-333. PubMed ID: 34688698 [TBL] [Abstract][Full Text] [Related]
20. Bifocal & Atropine in Myopia Study: Baseline Data and Methods. Huang J; Mutti DO; Jones-Jordan LA; Walline JJ Optom Vis Sci; 2019 May; 96(5):335-344. PubMed ID: 31046016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]